subject area of

• A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: Factoring in new trials and meta-analysis data  Academic Article
• Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C  Academic Article
• Enoxaparin in primary and facilitated percutaneous coronary intervention a formal prospective nonrandomized substudy of the finesse trial (facilitated intervention with enhanced reperfusion speed to stop events)  Academic Article
• Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy - Primary results of the SYNERGY randomized trial  Academic Article
• Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial  Academic Article
• Low-molecular-weight heparin in prevention of restenosis after angioplasty - results of enoxaparin restenosis (era) trial  Academic Article
• Low-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data  Academic Article
• Redefining medical treatment in the management of unstable angina  Academic Article